Dec 29, 2015 8:21 EST

EXtatin Inc.: involved in the research and development of a bio compatible molecule

iCrowdNewswire - Dec 29, 2015

EXtatin Inc.

  • Quality research and Management – Dr. Sheldon Joseph PhD is a qualified cell physiologist with experience cancer research and genetics. He is the principle investigator for the research and development of the company . Frederick Hawa is litigation lawyer (Osgoode) with a BSc (U of T) and MBA (Miami) who has many years of experience in the biotechnology R and D world
  • Immediate Investor interest – Extatin has a core of 50 or so interested individual investors who are prepared to invest $30,000 to $50,000 each should the company fulfill its goals of providing shares which can be traded on the public markets.

EXtatin is involved in the research and development of a bio compatible molecule to be introduced topically and sub-dermally in order to facilitate the detachment and disposal of tattoo ink laden cells. The experiments and research are being conducted on live tattooed skin from donors who have undergone surgical excision of the tattooed skin as part of plastic and cosmetic surgery procedures.

 

Contact Information:

Sheldon Mark Joseph
Frederick Simon Hawa

View Related News >
support